Nonprofit Partner

The Leukemia & Lymphoma SocietyLLS-brand-social-post-1.jpg

BEATING CANCER IS IN OUR BLOOD

The Leukemia & Lymphoma Society is at the forefront of the fight to cure cancer. We are the largest nonprofit dedicated to creating a world without blood cancers. Since 1949, we’ve invested nearly $1.3 billion in groundbreaking research, pioneering many of today’s most innovated approaches.
Beating cancer fact sheet

 

The LLS Mission:
Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

 

Research

LLS is at the forefront of the fight to cure cancer. Compared to other blood cancer nonprofits, LLS is the largest funder of cutting-edge research to advance cures. We have invested nearly $1.3 billion in research. We are leaders in advancing breakthroughs in immunotherapy, genomics and personalized medicine. This research saves lives. These revolutionary new treatments originally discovered through blood cancer research are now being tested in clinical trials for other cancers.
Learn more about our research investment
Lifesaving investment in research fact sheet

 

Patient Access

As the leading source of free blood cancer information, education and support for patients, survivors, families and healthcare professionals, LLS helps patients navigate their cancer treatment and ensures they have access to quality, affordable and coordinated care. Research will help us achieve an end to cancer. In the meantime, patients need help before, during and after their diagnosis and treatment. LLS is the leading nonprofit that does just that.
Learn more about our support resources

 

Policy and Advocacy

Through our nationwide grassroots network of more than 100,00 volunteers, we advocate for policies at the state and federal level in a commitment to remove barriers to care for cancer patients. Our efforts have helped increase federal research funds, speed the review and approval process of new therapies, and ensure patients are able to access lifesaving treatments. Many of the policies that we advocate for, at the state and federal levels, are universally beneficial for all cancer patients.
Learn more about policy and advocacy

 

Priority Research Initiatives

BEAT AML - We are revolutionizing acute myeloid leukemia (AML) treatment through the first collaborative precision medicine clinical trial in a blood cancer. Learn more: https://www.lls.org/research/bringing-precision-medicine-to-aml-patients

Myeloma - We’re taking new aim at myeloma through our dedicated research investment and multifaceted education and outreach efforts. Learn more

Pediatric Cancer - We’re setting out to disrupt how treatments are developed for pediatric cancers, while expanding the education and support we already provide to children and families. Learn more

 

Light The NightLTN_Wash_Park.png

The Leukemia & Lymphoma Society’s Light The Night Walk funds treatments that are saving the lives of patients today. LLS is making cures happen by providing patient support services, advocating for lifesaving treatments, and pioneering the most promising cancer research anywhere. And it’s all happening now. Not someday, but today. We bring hope instead of despair by working to ensure access to treatments for all blood cancer patients. We bring communities together to celebrate those who are fighting the disease and to honor those we have lost.

Each year friends, families and coworkers form teams to raise money in support of our mission. You can join approximately 1 million people at 140 inspirational evening walks across the US and Canada, walking to end cancer. This year, on Thursday September 23 at Washington Park in Denver, our teams and their communities Light The Night at our walk where we gather together to celebrate, honor and remember those touched by cancer.

You can learn more or register here.
When We Walk Cancer Runs flyer